Follow
Swapnil Talkar
Swapnil Talkar
Verified email at pg.ictmumbai.edu.in - Homepage
Title
Cited by
Cited by
Year
Transmucosal nanoparticles: toxicological overview
S Talkar, S Dhoble, A Majumdar, V Patravale
Cellular and molecular toxicology of nanoparticles, 37-57, 2018
242018
Gene therapy for prostate cancer: a review
SS Talkar, VB Patravale
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021
122021
An industrially viable technique for fabrication of docetaxel NLCs for oncotherapy
PB Kharkar, SS Talkar, VB Patravale
International Journal of Pharmaceutics 577, 119082, 2020
112020
A rapid and sensitive bio analytical RP-HPLC method for detection of docetaxel: development and validation
P Kharkar, S Talkar, VB Patravale
Indian J Pharm Educ 51 (4), 729-734, 2017
92017
Docetaxel loaded pomegranate seed oil based nanostructured lipid carriers: a potential alternative to current formulation
SS Talkar, PB Kharkar, VB Patravale
AAPS PharmSciTech 21, 1-11, 2020
82020
Nanosystems for oral delivery of immunomodulators
PB Kharkar, SS Talkar, NA Kadwadkar, VB Patravale
Nanostructures for Oral Medicine, 295-334, 2017
82017
Targeted Lipid-Based Nanoparticles for Nucleic Acid Delivery in Cancer Therapy
P Upadhaya, S Talkar, V Ghodake, N Kadwadkar, A Pandya, S Pulakkat, ...
Micro-and Nanotechnologies-Based Product Development, 95-114, 2021
2021
7 Targeted Lipid-Based
P Upadhaya, S Talkar, V Ghodake, N Kadwadkar, A Pandya, S Pulakkat, ...
Micro-and Nanotechnologies-Based Product Development, 95, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–8